Tempus AI

Tempus AI Days Payable Outstanding

The Days Payable Outstanding (DPO) of Tempus AI (TEM) as of Nov 20, 2026 is 63.15. In the previous year, Days Payable Outstanding (DPO) was 62.89 — a change of 0.42% (higher).

Days Payable Outstanding

63.15

YoY

0.42%

Last updated:

Days Payable Outstanding (DPO) of Tempus AI is 2025 63.15 . Days Payable Outstanding (DPO) of Tempus AI was 2024 62.89 . It decreases by 0.42% higher compared to the previous year.

The Tempus AI Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2019
106.41 USD
Jan 1, 2020
122.75 USD
Jan 1, 2021
70.72 USD
Jan 1, 2022
88.12 USD
Jan 1, 2023
80.86 USD
Jan 1, 2024
62.89 USD
Jan 1, 2025
63.15 USD
The Tempus AI Days Payable Outstanding history
YEARDays Payable OutstandingYoY
63.15+0.42%
62.89-22.23%
80.86-8.24%
88.12+24.61%
70.72-42.39%
122.75+15.36%
106.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc provides next generation diagnostics through genomics, data, and AI applications. Its genomics product line includes next generation sequencing, diagnostics, PCR, profiling, molecular genotyping, and pathology testing. The AI applications focus on algorithmic diagnostics, software as a medical device, and clinical decision support tools. The primary AI product Next uses machine learning to identify care gaps for oncology and cardiology patients. The company serves healthcare providers and life sciences organizations seeking personalized medicine solutions. Tempus AI Inc's revenue comes from its genomics and AI product lines. The genomics services are delivered through its laboratories, offering sequencing, diagnostics, and molecular testing. The AI applications, particularly Next, are sold as software solutions to healthcare institutions. The target customers are healthcare providers and life sciences companies that require advanced diagnostic tools for personalized treatment plans. The company operates in the Life Sciences Tools & Services industry, focusing on oncology and cardiology segments. The company's genomics product line generates revenue through laboratory services for molecular pathology testing. AI applications like Next are sold as medical device software, targeting healthcare institutions for clinical decision support. The primary segments served are oncology and cardiology, where personalized medicine is critical. The company's products are designed to integrate with existing healthcare data systems to improve patient care outcomes. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

Days Payable Outstanding (DPO) of Tempus AI is 63.15 in 2025.

Days Payable Outstanding (DPO) of Tempus AI changed from 62.89 to 63.15, representing a 0.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Tempus AI since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Tempus AI with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Tempus AI

All Key Metrics — Tempus AI